— Know what they know.
Not Investment Advice

COLL NASDAQ

Collegium Pharmaceutical, Inc.
1W: -2.3% 1M: -9.4% 3M: -41.2% YTD: -51.6% 1Y: -37.4% 3Y: -1.5% 5Y: +7.7%
$22.02
+0.18 (+0.82%)
 
Weekly Expected Move ±3.3%
$21 $21 $22 $23 $23
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 38 · $714.2M mcap · 32M float · 2.00% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
48.3 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 9.4%  ·  5Y Avg: 5.4%
Cost Advantage
44
Intangibles
42
Switching Cost
54
Network Effect
58
Scale
45
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. COLL shows a Weak competitive edge (48.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. ROIC of 9.4% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$45
Low
$48
Avg Target
$50
High
Based on 4 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$48.00
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-23 Oppenheimer — Initiated $50 — +119.5% $22.78
2026-09-09 Leerink Partners — Initiated $45 — +92.6% $23.37
2026-09-09 Truist Financial — $58 $49 -9 +109.7% $23.37
2026-08-19 Barclays — $56 $48 -8 +68.4% $28.50
2026-02-10 Truist Financial Les Sulewski $55 $58 +3 +25.5% $46.21
2026-01-09 Barclays — $58 $56 -2 +14.8% $48.78
2026-01-09 H.C. Wainwright — $50 $60 +10 +23.0% $48.78
2026-01-07 Truist Financial — Initiated $55 — +19.0% $46.21
2025-12-08 Barclays — Initiated $58 — +21.1% $47.91
2025-02-04 Piper Sandler David Amsellem $37 $36 -1 +16.4% $30.93
2024-11-11 Jefferies Glen Santangelo $44 $40 -4 +24.3% $32.18
2024-09-04 H.C. Wainwright Oren Livnat $47 $50 +3 +29.4% $38.65
2024-08-09 Piper Sandler David Amsellem $39 $37 -2 +6.9% $34.62
2024-07-30 H.C. Wainwright Oren Livnat Initiated $47 — +21.8% $38.60
2024-06-06 Jefferies Glen Santangelo Initiated $44 — +40.3% $31.36
2024-05-09 Piper Sandler David Amsellem Initiated $39 — +17.8% $33.11
2023-01-04 Needham — Initiated $35 — +29.7% $26.98

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
4
ROE
4
ROA
5
D/E
1
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. COLL receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-01 B B+
2026-08-12 B- B
2026-08-06 B+ B-
2026-07-01 B B+
2026-06-05 B+ B
2026-06-02 B B+
2026-05-18 B+ B
2026-05-07 B B+
2026-05-06 B+ B
2026-04-01 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 53 Grade C
Profitability
34
Balance Sheet
29
Earnings Quality
45
Growth
69
Value
42
Momentum
94
Safety
15
Cash Flow
90
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. COLL scores highest in Momentum (94/100) and lowest in Safety (15/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.08
Distress Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✗ ✓ ✗ ✗
Beneish M-Score
-2.72
Unlikely Manipulator
Ohlson O-Score
-5.31
Bankruptcy prob: 0.5%
Low Risk
Credit Rating
BB-
Score: 38.4/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 6.89x
Accruals: -15.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. COLL scores 1.08, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. COLL scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. COLL's score of -2.72 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. COLL's implied 0.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. COLL receives an estimated rating of BB- (score: 38.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). COLL's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
14.39x
PEG
0.49x
P/S
0.88x
P/B
2.29x
P/FCF
3.58x
P/OCF
3.56x
EV/EBITDA
3.25x
EV/Revenue
2.36x
EV/EBIT
7.94x
EV/FCF
5.80x
Earnings Yield
4.08%
FCF Yield
27.94%
Shareholder Yield
0.00%
Graham Number
$17.86
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 14.4x earnings, COLL trades at a reasonable valuation. Graham's intrinsic value formula yields $17.86 per share, 23% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.617
NI / EBT
×
Interest Burden
0.324
EBT / EBIT
×
EBIT Margin
0.296
EBIT / Rev
×
Asset Turnover
0.434
Rev / Assets
×
Equity Multiplier
6.852
Assets / Equity
=
ROE
17.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. COLL's ROE of 17.6% is driven by financial leverage (equity multiplier: 6.85x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$56.83
Price/Value
0.64x
Margin of Safety
36.30%
Premium
-36.30%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with COLL's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. COLL trades at a -36% premium to its adjusted intrinsic value of $56.83, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 14.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$22.02
Median 1Y
$21.71
5th Pctile
$9.61
95th Pctile
$49.08
Ann. Volatility
48.3%
Analyst Target
$48.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David Dieter Counsel
ve Vice President and General Counsel
$384,615 $3,189,732 $3,870,092
Colleen Tupper Financial
Vice President and Chief Financial Officer
$559,340 $2,484,486 $3,515,055
Scott Dreyer Commercial
Vice President and Chief Commercial Officer
$523,236 $2,160,473 $3,041,212
Shirley Kuhlmann President,
cutive Vice President, Chief Administrative Officer, General Counsel and Secretary
$115,522 $1,966,013 $2,783,583
Thomas Smith, M.D.
Executive Vice President and Chief Medical Officer
$492,959 $1,620,314 $2,446,008
Vikram Karnani
President and Chief Executive Officer
$875,000 $— $1,715,846

CEO Pay Ratio

3:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,715,846
Avg Employee Cost (SGA/emp): $652,891
Employees: 423

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
423
+18.5% YoY
Revenue / Employee
$1,845,312
Rev: $780,567,000
Profit / Employee
$148,629
NI: $62,870,000
SGA / Employee
$652,891
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 48.9% 36.8% 23.4% -15.6% -19.1% -12.6% -15.6% -5.6% 4.8% 24.7% 46.4% 47.9% 42.9% 32.6% 19.2% 16.2% 23.0% 23.7% 27.4% 17.6% 17.61%
ROA 14.9% 10.7% 4.5% -3.6% -4.4% -2.7% -2.4% -0.9% 0.8% 4.2% 8.0% 8.8% 6.3% 4.9% 3.2% 2.7% 3.6% 3.8% 4.6% 2.6% 2.57%
ROIC 49.2% 5.1% -1.2% -1.8% -1.2% 3.6% 7.5% 11.5% 8.4% 19.0% 25.8% 28.6% 13.5% 12.9% 10.9% 10.6% 12.7% 14.6% 18.8% 9.4% 9.40%
ROCE 14.1% 4.3% -1.6% -2.3% -1.6% 4.6% 6.0% 9.9% 14.8% 23.2% 31.3% 36.2% 16.9% 15.0% 12.4% 12.0% 14.4% 21.4% 22.3% 15.5% 15.50%
Gross Margin 58.5% -4.9% 57.9% 42.4% 46.3% 38.4% 53.5% 54.5% 58.7% 63.2% 63.1% 62.5% 60.8% 54.0% 54.8% 57.7% 61.7% 62.5% 60.6% 55.2% 55.18%
Operating Margin 17.9% -1.2% -12.0% 9.0% 16.1% 9.1% 17.0% 26.3% 32.9% 41.2% 34.1% 32.7% 21.9% 20.9% 12.2% 18.7% 30.4% 28.8% 16.5% 1.9% 1.85%
Net Margin 10.2% -91.5% -15.6% -4.2% 0.4% -5.6% -12.0% 9.6% 15.1% 21.3% 19.1% 13.5% 5.9% 6.9% 1.4% 6.4% 15.0% 8.3% 7.5% -7.5% -7.53%
EBITDA Margin 39.8% -61.8% 11.5% 40.1% 46.0% 43.1% 29.0% 57.5% 63.4% 67.8% 61.7% 55.2% 47.5% 53.0% 45.3% 50.1% 58.1% 1.5% 46.8% 35.4% 35.40%
FCF Margin 26.7% 36.7% 20.5% 21.4% 25.7% 26.4% 33.4% 43.8% 48.8% 48.4% 54.4% 47.8% 32.1% 32.2% 29.6% 28.5% 38.2% 42.0% 41.4% 40.6% 40.62%
OCF Margin 27.6% 37.4% 21.1% 21.9% 26.0% 26.8% 33.8% 44.0% 49.0% 48.5% 54.5% 48.0% 32.3% 32.5% 29.9% 28.8% 38.4% 42.2% 41.6% 40.8% 40.82%
ROE 3Y Avg snapshot only 25.70%
ROE 5Y Avg snapshot only 10.74%
ROA 3Y Avg snapshot only 4.67%
ROIC 3Y Avg snapshot only 9.49%
ROIC Economic snapshot only 8.48%
Cash ROA snapshot only 15.45%
Cash ROIC snapshot only 31.72%
CROIC snapshot only 31.56%
NOPAT Margin snapshot only 12.10%
Pretax Margin snapshot only 9.61%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 29.67%
SBC / Revenue snapshot only 5.56%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 6.92 8.91 16.02 -17.09 -12.93 -31.16 -28.04 -82.51 104.26 26.39 17.24 13.02 17.52 16.61 22.33 31.86 23.61 29.24 17.68 24.52 14.392
P/S Ratio 2.20 2.30 2.51 1.92 1.53 1.68 1.57 1.71 1.72 2.24 2.84 2.26 2.59 1.82 1.48 1.63 1.82 2.35 1.66 1.45 0.884
P/B Ratio 2.85 3.14 3.50 3.05 2.81 4.00 4.58 4.59 5.26 6.50 7.24 6.00 6.62 5.02 4.18 4.98 5.02 6.09 4.24 3.77 2.292
P/FCF 8.23 6.27 12.23 8.96 5.96 6.35 4.69 3.92 3.53 4.63 5.22 4.72 8.06 5.65 4.99 5.73 4.77 5.61 4.02 3.58 3.580
P/OCF 7.96 6.16 11.89 8.78 5.89 6.27 4.65 3.89 3.51 4.62 5.21 4.70 8.01 5.61 4.94 5.68 4.74 5.58 4.00 3.56 3.562
EV/EBITDA 5.85 8.20 23.49 16.76 11.44 7.58 6.61 5.80 5.16 5.31 5.40 4.44 6.65 5.40 4.89 5.08 5.12 3.95 2.81 3.25 3.245
EV/Revenue 2.43 2.56 4.97 3.94 3.18 2.83 2.59 2.53 2.48 2.88 3.39 2.75 3.85 2.92 2.45 2.49 2.66 3.04 2.15 2.36 2.355
EV/EBIT 11.88 40.24 -100.00 -65.46 -91.87 38.25 28.19 17.68 12.79 10.27 9.18 7.41 11.61 10.70 11.42 13.03 12.07 9.11 6.31 7.94 7.943
EV/FCF 9.11 6.98 24.20 18.37 12.40 10.72 7.75 5.77 5.08 5.96 6.23 5.76 11.99 9.08 8.28 8.73 6.95 7.24 5.19 5.80 5.798
Earnings Yield 14.5% 11.2% 6.2% -5.9% -7.7% -3.2% -3.6% -1.2% 1.0% 3.8% 5.8% 7.7% 5.7% 6.0% 4.5% 3.1% 4.2% 3.4% 5.7% 4.1% 4.08%
FCF Yield 12.2% 15.9% 8.2% 11.2% 16.8% 15.7% 21.3% 25.5% 28.4% 21.6% 19.2% 21.2% 12.4% 17.7% 20.1% 17.5% 21.0% 17.8% 24.9% 27.9% 27.94%
PEG Ratio snapshot only 0.485
EV/OCF snapshot only 5.769
EV/Gross Profit snapshot only 3.924
Acquirers Multiple snapshot only 12.008
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $17.86
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.35 1.13 0.97 0.99 0.98 0.97 1.21 1.24 1.16 1.17 1.21 1.11 0.97 0.95 1.08 1.18 1.36 1.57 1.71 1.03 1.031
Quick Ratio 1.29 1.07 0.76 0.80 0.82 0.86 1.13 1.18 1.08 1.10 1.14 1.04 0.88 0.88 1.01 1.10 1.27 1.48 1.62 0.84 0.839
Debt/Equity 1.08 1.28 3.97 3.82 3.71 3.64 4.49 3.80 4.02 3.45 2.84 2.58 3.73 3.75 3.60 3.57 3.41 3.12 2.59 2.75 2.750
Net Debt/Equity 0.31 0.36 3.42 3.20 3.03 2.75 2.99 2.18 2.31 1.86 1.40 1.33 3.22 3.04 2.76 2.61 2.29 1.77 1.24 2.34 2.335
Debt/Assets 0.36 0.37 0.62 0.61 0.61 0.60 0.66 0.63 0.61 0.59 0.57 0.53 0.53 0.52 0.52 0.52 0.58 0.57 0.49 0.40 0.402
Debt/EBITDA 2.00 2.99 13.46 10.25 7.27 4.09 3.92 3.25 2.74 2.19 1.77 1.56 2.52 2.51 2.54 2.39 2.38 1.57 1.32 1.46 1.462
Net Debt/EBITDA 0.57 0.84 11.62 8.58 5.94 3.09 2.61 1.86 1.58 1.18 0.88 0.80 2.18 2.04 1.94 1.75 1.61 0.89 0.63 1.24 1.242
Interest Coverage 2.78 0.84 -0.64 -0.56 -0.26 0.54 0.61 0.93 1.25 1.91 2.64 2.94 2.81 2.33 1.84 1.64 1.94 1.55 1.66 1.48 1.480
Equity Multiplier 2.95 3.41 6.36 6.30 6.09 6.03 6.76 6.05 6.58 5.85 5.02 4.86 6.98 7.27 6.96 6.86 5.85 5.49 5.29 6.85 6.847
Cash Ratio snapshot only 0.219
Debt Service Coverage snapshot only 3.622
Cash to Debt snapshot only 0.151
FCF to Debt snapshot only 0.383
Defensive Interval snapshot only 463.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.47 0.41 0.29 0.32 0.37 0.50 0.43 0.44 0.46 0.49 0.49 0.51 0.43 0.45 0.48 0.53 0.47 0.47 0.49 0.43 0.434
Inventory Turnover 7.51 7.65 2.71 3.45 4.96 7.96 5.07 5.34 5.37 6.10 7.07 8.14 6.25 7.49 8.21 9.28 8.51 8.30 7.83 4.27 4.268
Receivables Turnover 2.89 2.93 2.10 2.18 2.10 3.21 3.04 2.94 2.90 3.13 3.20 3.28 2.92 3.09 3.29 3.56 3.27 3.55 3.48 3.25 3.245
Payables Turnover 18.22 17.78 20.67 23.69 26.46 66.24 83.75 61.26 47.00 39.49 50.31 90.83 66.39 40.25 23.55 46.04 60.04 43.49 25.38 32.10 32.102
DSO 126 125 174 167 174 114 120 124 126 117 114 111 125 118 111 102 111 103 105 112 112.5 days
DIO 49 48 135 106 74 46 72 68 68 60 52 45 58 49 44 39 43 44 47 86 85.5 days
DPO 20 21 18 15 14 6 4 6 8 9 7 4 5 9 16 8 6 8 14 11 11.4 days
Cash Conversion Cycle 155 152 291 258 234 154 188 186 186 167 158 152 178 158 140 134 148 138 137 187 186.6 days
Fixed Asset Turnover snapshot only 55.955
Operating Cycle snapshot only 198.0 days
Cash Velocity snapshot only 6.243
Capital Intensity snapshot only 2.643
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 5.8% -10.7% -15.0% -3.9% 11.0% 67.6% 92.4% 71.3% 51.1% 22.2% 8.0% 7.4% 9.6% 11.4% 17.2% 22.6% 26.3% 23.6% 19.9% 14.3% 14.31%
Net Income 4.9% 1.7% 2.0% -1.3% -1.4% -1.3% -1.7% 68.3% 1.2% 2.9% 4.2% 10.0% 8.8% 43.7% -53.0% -63.7% -34.0% -9.1% 70.7% 32.1% 32.10%
EPS 4.7% 1.8% 24.6% -1.4% -1.4% -1.4% -1.7% 74.9% 1.2% 2.6% 3.6% 10.5% 9.3% 47.9% -40.6% -62.5% -32.8% -8.2% 40.0% 59.0% 59.02%
FCF 6.0% 15.0% -51.7% -34.0% 6.8% 20.7% 2.1% 2.5% 1.9% 1.2% 75.6% 17.2% -27.8% -25.9% -36.2% -26.8% 50.3% 61.1% 67.8% 62.7% 62.67%
EBITDA 54.3% -26.6% -58.9% -47.7% -25.7% 1.0% 2.6% 2.2% 1.6% 77.6% 72.6% 52.7% 32.1% 10.9% -6.4% -3.1% 13.3% 75.5% 83.3% 69.2% 69.17%
Op. Income 71.7% -68.7% -1.2% -1.3% -1.2% 89.0% 6.0% 5.9% 10.3% 4.0% 1.8% 1.2% 65.3% 1.8% -25.9% -36.3% -18.1% 5.7% 33.6% 22.2% 22.17%
OCF Growth snapshot only 62.14%
Asset Growth snapshot only 34.10%
Equity Growth snapshot only 34.32%
Debt Growth snapshot only 3.46%
Shares Change snapshot only -16.93%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 14.4% -0.4% -2.1% 2.3% 6.9% 16.1% 20.7% 21.2% 21.1% 22.3% 20.8% 20.9% 22.5% 31.6% 34.5% 31.1% 27.9% 18.9% 14.9% 14.6% 14.60%
Revenue 5Y 2.8% 1.8% 1.3% 1.1% 80.3% 74.7% 42.3% 27.5% 20.2% 15.1% 14.3% 14.5% 15.2% 16.3% 17.3% 18.6% 19.7% 20.3% 19.9% 19.9% 19.90%
EPS 3Y — — — — — — — — -24.7% 15.6% 30.2% -1.5% -8.2% -6.3% 1.7% — — — — — —
EPS 5Y — — — — — — — — — — — — — — — 1.8% 24.2% 16.0% 12.9% -10.6% -10.61%
Net Income 3Y — — — — — — — — -20.0% 21.6% 30.5% -2.2% -5.1% -1.1% 0.9% — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — 1.8% 27.1% 18.6% 12.3% -14.8% -14.80%
EBITDA 3Y 42.0% -2.0% -5.9% 19.6% 74.0% — 1.4% 68.2% 44.0% 37.7% 36.2% 36.5% 36.8% 58.0% 79.3% 67.6% 57.4% 51.2% 43.6% 35.8% 35.79%
EBITDA 5Y — — — — — — — 80.4% 40.9% 27.4% 38.7% 52.7% 78.6% — 85.8% 47.8% 34.9% 38.4% 34.1% 33.0% 33.04%
Gross Profit 3Y 34.5% 9.5% 6.3% 6.8% 9.2% 26.7% 26.9% 23.3% 20.5% 22.0% 20.1% 21.7% 23.9% 35.8% 38.7% 40.1% 39.9% 30.3% 26.6% 23.1% 23.13%
Gross Profit 5Y 2.5% 1.5% 1.1% 87.5% 55.7% 51.9% 39.8% 30.8% 28.4% 23.2% 23.3% 24.5% 25.2% 29.6% 26.9% 23.7% 21.9% 20.8% 19.7% 19.6% 19.59%
Op. Income 3Y — — — — — — — 93.0% 44.4% 43.7% 38.4% 41.3% 42.6% 1.1% — — — 75.3% 40.9% 19.7% 19.67%
Op. Income 5Y — — — — — — — — — — — — — — — 58.8% 32.5% 26.1% 21.3% 17.0% 17.02%
FCF 3Y -1.5% -11.2% -23.0% -6.2% 25.4% 79.1% 89.7% 62.3% 48.1% 45.9% 38.5% 39.4% 30.3% 26.0% 51.9% 44.3% 46.0% 38.8% 23.4% 11.8% 11.76%
FCF 5Y — — — — — — — 43.2% 24.0% 13.6% 20.2% 27.6% 32.5% 57.0% 50.2% 29.7% 28.7% 30.0% 23.2% 26.4% 26.38%
OCF 3Y -7.5% -15.1% -24.0% -8.7% 20.0% 64.7% 81.4% 58.9% 45.4% 43.0% 36.6% 37.3% 29.1% 25.6% 51.0% 43.7% 45.7% 38.4% 23.2% 11.7% 11.74%
OCF 5Y — — — — — — — 31.8% 18.7% 10.2% 18.7% 25.1% 28.9% 49.1% 46.2% 28.1% 27.3% 28.5% 22.3% 25.3% 25.29%
Assets 3Y 4.7% 33.4% 61.8% 60.4% 58.1% 56.5% 24.1% 23.3% 22.3% 21.1% 19.9% 13.9% 30.1% 34.0% 9.4% 8.5% 10.2% 12.2% 10.8% 20.7% 20.72%
Assets 5Y 49.7% 33.7% 54.9% 58.5% 57.8% 54.0% 11.8% 12.5% 12.7% 31.5% 30.5% 28.4% 40.0% 40.3% 20.8% 19.7% 20.1% 20.8% 20.7% 24.5% 24.51%
Equity 3Y 52.5% 30.4% 31.4% 32.0% 32.8% 30.6% 8.4% 8.8% 1.2% 1.7% 9.3% -5.1% -2.3% 4.1% 6.1% 5.5% 11.7% 15.7% 20.2% 15.8% 15.81%
Book Value 3Y 47.8% 29.9% 31.0% 31.3% 31.4% 30.6% 9.2% 1.8% -4.8% -3.4% 9.1% -4.4% -5.6% -1.4% 7.0% 0.7% 6.9% 9.4% 14.2% 27.0% 27.04%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.88 0.66 0.63 0.72 0.81 0.83 0.79 0.81 0.82 0.68 0.64 0.73 0.82 0.83 0.81 0.87 0.91 0.98 0.98 0.99 0.988
Earnings Stability 0.87 0.97 0.97 0.41 0.34 0.42 0.33 0.09 0.11 0.31 0.37 0.13 0.09 0.28 0.19 0.03 0.04 0.13 0.14 0.00 0.001
Margin Stability 0.61 0.63 0.67 0.68 0.65 0.63 0.83 0.86 0.82 0.85 0.83 0.82 0.82 0.79 0.83 0.86 0.87 0.89 0.88 0.90 0.905
Rev. Growth Consistency 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.86 0.96 0.50 0.87 0.872
Earnings Smoothness 0.00 0.09 0.98 — — — — — — — — — 0.00 0.64 0.28 0.07 0.59 0.90 0.48 0.72 0.723
ROE Trend 0.43 0.41 0.14 -0.39 -0.47 -0.38 -0.40 -0.18 -0.05 0.13 0.39 0.58 0.46 0.24 0.06 -0.05 -0.00 -0.07 -0.06 -0.16 -0.155
Gross Margin Trend 0.14 0.08 0.02 -0.07 -0.12 -0.11 -0.11 -0.05 -0.01 0.08 0.11 0.15 0.15 0.08 0.05 0.02 0.00 0.01 0.02 0.01 0.007
FCF Margin Trend 0.05 0.19 -0.02 -0.03 -0.01 -0.06 0.05 0.17 0.23 0.17 0.27 0.15 -0.05 -0.05 -0.14 -0.17 -0.02 0.02 -0.01 0.02 0.024
Sustainable Growth Rate 48.9% 36.8% 23.4% — — — — — 4.8% 24.7% 46.4% 47.9% 42.9% 32.6% 19.2% 16.2% 23.0% 23.7% 27.4% 17.6% 17.61%
Internal Growth Rate 17.6% 12.0% 4.7% — — — — — 0.8% 4.3% 8.7% 9.7% 6.7% 5.2% 3.3% 2.8% 3.7% 3.9% 4.8% 2.6% 2.64%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.87 1.45 1.35 -1.95 -2.20 -4.97 -6.04 -21.19 29.70 5.71 3.31 2.77 2.19 2.96 4.52 5.61 4.98 5.24 4.42 6.89 6.886
FCF/OCF 0.97 0.98 0.97 0.98 0.99 0.99 0.99 0.99 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 0.99 0.99 1.00 1.00 0.995
FCF/Net Income snapshot only 6.851
OCF/EBITDA snapshot only 0.562
CapEx/Revenue 0.9% 0.7% 0.6% 0.4% 0.3% 0.3% 0.3% 0.2% 0.2% 0.1% 0.2% 0.2% 0.2% 0.3% 0.3% 0.2% 0.2% 0.2% 0.2% 0.2% 0.20%
CapEx/Depreciation snapshot only 0.005
Accruals Ratio 0.02 -0.05 -0.02 -0.11 -0.14 -0.16 -0.17 -0.20 -0.22 -0.20 -0.19 -0.16 -0.07 -0.10 -0.11 -0.13 -0.14 -0.16 -0.16 -0.15 -0.151
Sloan Accruals snapshot only -0.222
Cash Flow Adequacy snapshot only 200.805
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 3.5% 50.1% 75.6% — — — — — 6.4% 1.6% 80.4% 1.1% 67.7% 86.8% 1.4% 1.4% 85.8% 39.9% 33.5% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.5% 5.6% 4.7% 5.4% 7.0% 1.8% 1.7% 1.5% 6.1% 5.9% 4.7% 8.5% 3.9% 5.2% 6.1% 4.3% 3.6% 1.4% 1.9% 0.0% 0.00%
Net Buyback Yield 0.5% 5.6% 4.7% 5.4% 6.9% 1.8% 1.7% 1.4% 6.0% 5.8% 4.6% 8.0% 3.5% 4.7% 5.5% 4.3% 3.4% 1.2% 1.5% -0.4% -0.43%
Total Shareholder Return 0.5% 5.6% 4.7% 5.4% 6.9% 1.8% 1.7% 1.4% 6.0% 5.8% 4.6% 8.0% 3.5% 4.7% 5.5% 4.3% 3.4% 1.2% 1.5% -0.4% -0.43%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 2.42 -21.20 -1.23 0.67 0.71 0.87 0.96 1.82 0.42 0.64 0.72 0.71 0.69 0.70 0.67 0.68 0.72 0.68 0.69 0.62 0.617
Interest Burden (EBT/EBIT) 0.64 -0.19 2.56 2.77 4.78 -0.84 -0.63 -0.08 0.20 0.48 0.62 0.66 0.64 0.57 0.46 0.39 0.49 0.36 0.40 0.32 0.324
EBIT Margin 0.20 0.06 -0.05 -0.06 -0.03 0.07 0.09 0.14 0.19 0.28 0.37 0.37 0.33 0.27 0.21 0.19 0.22 0.33 0.34 0.30 0.296
Asset Turnover 0.47 0.41 0.29 0.32 0.37 0.50 0.43 0.44 0.46 0.49 0.49 0.51 0.43 0.45 0.48 0.53 0.47 0.47 0.49 0.43 0.434
Equity Multiplier 3.27 3.43 5.17 4.35 4.33 4.69 6.55 6.17 6.32 5.94 5.79 5.43 6.81 6.62 6.01 5.90 6.37 6.26 6.00 6.85 6.852
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $2.85 $2.10 $1.27 $-1.04 $-1.24 $-0.74 $-0.86 $-0.26 $0.21 $1.17 $2.25 $2.47 $2.21 $1.73 $1.34 $0.93 $1.48 $1.58 $1.87 $1.48 $1.48
Book Value/Share $6.92 $5.95 $5.82 $5.81 $5.70 $5.80 $5.24 $4.69 $4.25 $4.73 $5.36 $5.36 $5.83 $5.71 $7.14 $5.94 $6.97 $7.60 $7.80 $9.61 $9.61
Tangible Book/Share $-0.95 $-1.93 $-18.72 $-17.05 $-15.70 $-15.08 $-14.11 $-9.93 $-9.78 $-8.72 $-7.21 $-6.68 $-21.38 $-20.57 $-22.91 $-17.82 $-15.11 $-12.94 $-11.17 $-32.79 $-32.79
Revenue/Share $8.98 $8.11 $8.10 $9.22 $10.46 $13.81 $15.30 $12.53 $13.00 $13.73 $13.68 $14.28 $14.92 $15.74 $20.23 $18.09 $19.20 $19.66 $19.88 $24.90 $24.90
FCF/Share $2.40 $2.98 $1.66 $1.98 $2.69 $3.65 $5.11 $5.49 $6.34 $6.64 $7.44 $6.83 $4.79 $5.07 $5.99 $5.16 $7.34 $8.25 $8.23 $10.11 $10.11
OCF/Share $2.48 $3.03 $1.71 $2.02 $2.72 $3.70 $5.16 $5.52 $6.37 $6.66 $7.46 $6.85 $4.82 $5.11 $6.04 $5.21 $7.38 $8.29 $8.26 $10.16 $10.16
Cash/Share $5.33 $5.46 $3.17 $3.61 $3.88 $5.17 $7.85 $7.60 $7.24 $7.52 $7.68 $6.73 $2.99 $4.06 $6.02 $5.69 $7.75 $10.24 $10.53 $3.99 $3.99
EBITDA/Share $3.74 $2.54 $1.72 $2.17 $2.91 $5.17 $6.00 $5.47 $6.24 $7.46 $8.58 $8.86 $8.63 $8.52 $10.13 $8.87 $9.96 $15.11 $15.22 $18.07 $18.07
Debt/Share $7.46 $7.58 $23.09 $22.20 $21.18 $21.12 $23.49 $17.79 $17.08 $16.33 $15.20 $13.85 $21.77 $21.42 $25.71 $21.22 $23.74 $23.69 $20.17 $26.43 $26.43
Net Debt/Share $2.14 $2.12 $19.93 $18.59 $17.30 $15.95 $15.64 $10.20 $9.84 $8.81 $7.53 $7.13 $18.78 $17.37 $19.68 $15.53 $15.99 $13.45 $9.64 $22.44 $22.44
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 1.079
Altman Z-Prime snapshot only 1.331
Piotroski F-Score 5 6 4 3 3 5 4 6 7 8 8 8 7 6 5 6 7 7 8 6 6
Beneish M-Score -1.54 -8.05 -1.56 -1.51 -2.20 -0.57 -2.93 -3.73 -3.73 -3.65 -3.53 -3.34 -2.43 -2.39 -2.42 -2.58 -3.12 -3.42 -3.15 -2.72 -2.718
Ohlson O-Score snapshot only -5.309
Net-Net WC snapshot only $-37.46
EVA snapshot only $-6252250.35
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB-
Credit Score 48.18 35.09 12.51 12.41 17.27 22.77 29.11 32.27 37.37 45.42 56.16 55.64 41.61 36.94 36.56 35.85 42.70 50.67 46.66 38.35 38.353
Credit Grade snapshot only 13
Credit Trend snapshot only 2.507
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 30
Sector Credit Rank snapshot only 32

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms